Incyte EPS - Earnings per Share 2006-2021 | INCY

Incyte annual and quarterly earnings per share history from 2006 to 2021. Earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
  • Incyte EPS for the quarter ending March 31, 2021 was $0.24, a 107.21% decline year-over-year.
  • Incyte EPS for the twelve months ending March 31, 2021 was $2.21, a 226.29% decline year-over-year.
  • Incyte 2020 annual EPS was $-1.36, a 166.34% decline from 2019.
  • Incyte 2019 annual EPS was $2.05, a 301.96% increase from 2018.
  • Incyte 2018 annual EPS was $0.51, a 133.33% decline from 2017.
Incyte Annual EPS
2020 $-1.36
2019 $2.05
2018 $0.51
2017 $-1.53
2016 $0.54
2015 $0.03
2014 $-0.29
2013 $-0.56
2012 $-0.34
2011 $-1.49
2010 $-0.26
2009 $-2.06
2008 $-1.99
2007 $-1.03
2006 $-0.89
2005 $-1.24
Incyte Quarterly EPS
2021-03-31 $0.24
2020-12-31 $0.72
2020-09-30 $-0.07
2020-06-30 $1.32
2020-03-31 $-3.33
2019-12-31 $0.51
2019-09-30 $0.59
2019-06-30 $0.48
2019-03-31 $0.47
2018-12-31 $0.32
2018-09-30 $0.14
2018-06-30 $0.24
2018-03-31 $-0.19
2017-12-31 $-0.68
2017-09-30 $0.17
2017-06-30 $-0.06
2017-03-31 $-0.96
2016-12-31 $0.05
2016-09-30 $0.19
2016-06-30 $0.18
2016-03-31 $0.12
2015-12-31 $0.31
2015-09-30 $-0.22
2015-06-30 $0.05
2015-03-31 $-0.11
2014-12-31 $-0.19
2014-09-30 $0.33
2014-06-30 $-0.22
2014-03-31 $-0.21
2013-12-31 $-0.28
2013-09-30 $-0.14
2013-06-30 $-0.02
2013-03-31 $-0.12
2012-12-31 $0.16
2012-09-30 $-0.17
2012-06-30 $0.03
2012-03-31 $-0.36
2011-12-31 $-0.45
2011-09-30 $-0.42
2011-06-30 $-0.41
2011-03-31 $-0.21
2010-12-31 $0.28
2010-09-30 $-0.26
2010-06-30 $0.02
2010-03-31 $-0.30
2009-12-31 $-0.80
2009-09-30 $-0.44
2009-06-30 $-0.41
2009-03-31 $-0.41
2008-12-31 $-0.50
2008-09-30 $-0.48
2008-06-30 $-0.54
2008-03-31 $-0.47
2007-12-31 $-0.26
2007-09-30 $-0.29
2007-06-30 $-0.22
2007-03-31 $-0.26
2006-12-31 $-0.25
2006-09-30 $-0.19
2006-06-30 $-0.24
2006-03-31 $-0.21
2005-12-31 $-0.34
2005-09-30 $-0.36
2005-06-30 $-0.30
2005-03-31 $-0.24
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $17.290B $2.667B
Incyte Corporation is a Wilmington, Delaware-based biopharmaceutical company focused on the discovery, development, and commercialization of proprietary therapeutics. Their first commercial product, Jakafi (ruxolitinib), is approved in the United States for patients with intermediate or high-risk myelofibrosis and for patients with polycythemia vera who have had an inadequate response to or are intolerant of hydroxyurea. They have a diverse and growing portfolio of product candidates, including both small and large molecules.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $151.744B 10.52
Amgen (AMGN) United States $140.616B 15.17
Moderna (MRNA) United States $129.886B 258.78
CSL (CSLLY) Australia $96.596B 0.00
Gilead Sciences (GILD) United States $86.099B 9.17
Illumina (ILMN) United States $71.032B 102.43
BioNTech SE (BNTX) Germany $67.863B 49.21
Regeneron Pharmaceuticals (REGN) United States $62.528B 17.90
Vertex Pharmaceuticals (VRTX) United States $50.743B 20.90
Biogen (BIIB) United States $49.135B 13.35
BeiGene (BGNE) Cayman Islands $29.722B 0.00
Genmab (GMAB) Denmark $29.131B 34.12
Genmab (GNMSF) Denmark $27.696B 6.37
Seagen (SGEN) United States $26.011B 44.93
Horizon Therapeutics Public (HZNP) Ireland $22.493B 28.76
Alnylam Pharmaceuticals (ALNY) United States $21.371B 0.00
Exact Sciences (EXAS) United States $20.248B 0.00
Bio-Rad Laboratories (BIO.B) United States $20.098B 48.83
Bio-Techne Corp (TECH) United States $18.247B 95.95
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $17.427B 0.00
ARGENX SE-ADR (ARGX) Netherlands $16.242B 0.00
Novavax (NVAX) United States $15.552B 0.00
Zai Lab (ZLAB) China $15.280B 0.00
BioMarin Pharmaceutical (BMRN) United States $14.338B 130.77
Guardant Health (GH) United States $12.078B 0.00
QIAGEN (QGEN) Netherlands $11.705B 20.78
Repligen (RGEN) United States $11.311B 101.99
CureVac (CVAC) Germany $10.295B 0.00
Intellia Therapeutics (NTLA) United States $10.079B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $9.454B 0.00
Mirati Therapeutics (MRTX) United States $8.196B 0.00
Fate Therapeutics (FATE) United States $8.083B 0.00
Biohaven Pharmaceutical Holding (BHVN) United States $7.999B 0.00
Denali Therapeutics (DNLI) United States $7.822B 280.61
Acceleron Pharma (XLRN) United States $7.418B 0.00
Legend Biotech (LEGN) United States $6.524B 0.00
Ascendis Pharma (ASND) Denmark $6.317B 0.00
Halozyme Therapeutics (HALO) United States $6.047B 33.18
SWEDISH ORP BIO (BIOVF) Sweden $6.000B 21.50
I-Mab (IMAB) China $5.997B 0.00
Beam Therapeutics (BEAM) United States $5.956B 0.00
Twist Bioscience (TWST) United States $5.940B 0.00
Ultragenyx Pharmaceutical (RARE) United States $5.638B 0.00
Sarepta Therapeutics (SRPT) United States $5.513B 0.00
Exelixis (EXEL) United States $5.309B 84.70
Adaptive Biotechnologies (ADPT) United States $5.291B 0.00
NeoGenomics (NEO) United States $5.283B 896.00
Apellis Pharmaceuticals (APLS) United States $5.274B 0.00
Blueprint Medicines (BPMC) United States $4.982B 15.17
Vir Biotechnology (VIR) United States $4.857B 0.00
Reata Pharmaceuticals (RETA) United States $4.657B 0.00
AbCellera Biologics (ABCL) $4.343B 0.00
Arvinas (ARVN) United States $4.140B 0.00
SpringWorks Therapeutics (SWTX) United States $4.023B 0.00
Galapagos (GLPG) Belgium $3.939B 0.00
Certara (CERT) United States $3.933B 0.00
Arena Pharmaceuticals (ARNA) United States $3.917B 0.00
Alkermes (ALKS) Ireland $3.875B 0.00
ACADIA Pharmaceuticals (ACAD) United States $3.561B 0.00
Emergent Biosolutions (EBS) United States $3.411B 6.79
Berkeley Lights (BLI) United States $3.259B 0.00
Intra-Cellular Therapies (ITCI) United States $3.006B 0.00
Editas Medicine (EDIT) United States $2.917B 0.00
Dicerna Pharmaceuticals (DRNA) United States $2.913B 0.00
Heska (HSKA) United States $2.625B 1144.45
Sorrento Therapeutics (SRNE) United States $2.619B 0.00
Insmed (INSM) United States $2.589B 0.00
Kymera Therapeutics (KYMR) United States $2.584B 0.00
Alector (ALEC) United States $2.533B 0.00
Instil Bio (TIL) United States $2.498B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $2.489B 0.00
Myriad Genetics (MYGN) United States $2.479B 0.00
Vericel (VCEL) United States $2.449B 660.50
ALX Oncology Holdings (ALXO) United States $2.411B 0.00
Arcus Biosciences (RCUS) United States $2.344B 0.00
Amicus Therapeutics (FOLD) United States $2.325B 0.00
Prothena (PRTA) Ireland $2.268B 0.00
Morphic Holding (MORF) United States $2.176B 0.00
Revance Therapeutics (RVNC) United States $2.165B 0.00
Cytokinetics (CYTK) United States $2.159B 0.00
MorphoSys AG (MOR) Germany $2.145B 0.00
Seer (SEER) $2.112B 0.00
Atea Pharmaceuticals (AVIR) United States $2.112B 0.00
Celldex Therapeutics (CLDX) United States $2.060B 0.00
Protagonist Therapeutics (PTGX) United States $2.058B 0.00
Ligand Pharmaceuticals (LGND) United States $2.036B 34.06
Deciphera Pharmaceuticals (DCPH) United States $1.928B 0.00
Myovant Sciences (MYOV) United Kingdom $1.916B 0.00
Global Blood Therapeutics (GBT) United States $1.833B 0.00
Bluebird Bio (BLUE) United States $1.820B 0.00
Inovio Pharmaceuticals (INO) United States $1.809B 0.00
Genetron Holdings (GTH) China $1.752B 0.00
C4 Therapeutics (CCCC) United States $1.731B 0.00
Bionano Genomics (BNGO) United States $1.718B 0.00
Castle Biosciences (CSTL) United States $1.711B 0.00
Harmony Biosciences Holdings (HRMY) United States $1.671B 0.00
Zymeworks (ZYME) Canada $1.668B 0.00
NGM Biopharmaceuticals (NGM) United States $1.633B 0.00
PHARMA MAR SA (PHMMF) Spain $1.628B 0.00
Amarin (AMRN) Ireland $1.626B 0.00
REGENXBIO (RGNX) United States $1.588B 0.00
Avid Bioservices (CDMO) United States $1.564B 640.00
ADC Therapeutics SA (ADCT) Switzerland $1.518B 0.00
Y-mAbs Therapeutics (YMAB) United States $1.510B 0.00
Immunocore Holdings (IMCR) United Kingdom $1.497B 0.00
Sangamo Therapeutics (SGMO) United States $1.462B 0.00
Ocugen (OCGN) United States $1.403B 0.00
PureTech Health (PRTC) United States $1.375B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $1.372B 0.00
Codexis (CDXS) United States $1.368B 0.00
Nurix Therapeutics (NRIX) United States $1.363B 0.00
BioAtla (BCAB) United States $1.347B 0.00
Zealand Pharma (ZEAL) Denmark $1.310B 0.00
MiMedx (MDXG) United States $1.298B 0.00
Agenus (AGEN) United States $1.241B 0.00
Repare Therapeutics (RPTX) Canada $1.241B 0.00
UniQure (QURE) Netherlands $1.219B 0.00
Forma Therapeutics Holdings (FMTX) United States $1.169B 0.00
Northwest Biotherapeutics (NWBO) United States $1.157B 0.00
Precigen (PGEN) United States $1.148B 0.00
Scholar Rock Holding (SRRK) United States $1.137B 0.00
MannKind (MNKD) United States $1.116B 0.00
Dynavax Technologies (DVAX) United States $1.113B 0.00
Inhibrx (INBX) United States $1.088B 0.00
Vanda Pharmaceuticals (VNDA) United States $1.079B 34.05
Zealand Pharma (ZLDPF) Denmark $1.035B 0.00
Nkarta (NKTX) United States $1.010B 0.00
KaloBios Pharmaceuticals (HGEN) United States $1.004B 0.00
Shattuck Labs (STTK) United States $0.963B 0.00
Coherus BioSciences (CHRS) United States $0.961B 0.00
Mesoblast (MESO) Australia $0.930B 0.00
Pliant Therapeutics (PLRX) United States $0.926B 0.00
Adagene (ADAG) China $0.900B 0.00
Keros Therapeutics (KROS) United States $0.883B 0.00
Avidity Biosciences (RNA) United States $0.873B 0.00
Prometheus Biosciences (RXDX) United States $0.870B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.841B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $0.829B 0.00
Mersana Therapeutics (MRSN) United States $0.827B 0.00
Sutro Biopharma (STRO) United States $0.813B 0.00
RAPT THERAPTICS (RAPT) United States $0.804B 0.00
Travere Therapeutics (TVTX) United States $0.785B 0.00
VBI Vaccines (VBIV) United States $0.775B 0.00
G1 THERAPEUTICS (GTHX) United States $0.759B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.745B 0.00
Kadmon Holdings (KDMN) United States $0.743B 0.00
IDEAYA Biosciences (IDYA) United States $0.732B 0.00
Seres Therapeutics (MCRB) United States $0.729B 0.00
Epizyme (EPZM) United States $0.722B 0.00
Pharming Group (PHAR) Netherlands $0.716B 0.00
Merus (MRUS) Netherlands $0.712B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.709B 0.00
ChromaDex (CDXC) United States $0.707B 0.00
AnaptysBio (ANAB) United States $0.706B 0.00
Curis (CRIS) United States $0.705B 0.00
Pharming Group (PHGUF) Netherlands $0.701B 22.40
SESEN BIO, INC (SESN) United States $0.700B 0.00
Affimed (AFMD) Germany $0.652B 0.00
MeiraGTx Holdings (MGTX) United States $0.646B 0.00
Sinovac Biotech (SVA) China $0.642B 6.47
Cara Therapeutics (CARA) United States $0.631B 54.83
Cellectis S.A (CLLS) France $0.630B 0.00
Akoya Biosciences (AKYA) United States $0.618B 0.00
ALBIREO PHARMA (ALBO) United States $0.609B 0.00
Precision BioSciences (DTIL) United States $0.605B 0.00
Verastem (VSTM) United States $0.598B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.586B 0.00
Anika Therapeutics (ANIK) United States $0.576B 0.00
Intercept Pharmaceuticals (ICPT) United States $0.570B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $0.563B 0.00
Inventiva S.A (IVA) France $0.560B 0.00
VistaGen Therapeutics (VTGN) United States $0.557B 0.00
DBV Technologies S.A (DBVT) France $0.553B 0.00
Clene (CLNN) United States $0.547B 0.00
AC Immune SA (ACIU) Switzerland $0.543B 0.00
Clovis Oncology (CLVS) United States $0.525B 0.00
Brooklyn ImmunoTherapeutics (BTX) United States $0.514B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.513B 0.00
Vaccitech (VACC) United Kingdom $0.507B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.496B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.494B 0.00
XBiotech (XBIT) United States $0.477B 0.00
Bolt Biotherapeutics (BOLT) United States $0.467B 0.00
Compugen (CGEN) Israel $0.464B 0.00
Forte Biosciences (FBRX) United States $0.442B 0.00
Cybin (CLXPF) Canada $0.441B 0.00
Lineage Cell Therapeutics (LCTX) United States $0.435B 0.00
Oncobiologics (OTLK) United States $0.431B 0.00
Spero Therapeutics (SPRO) United States $0.429B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.418B 0.00
Kindred Biosciences (KIN) United States $0.417B 0.00
ANI Pharmaceuticals (ANIP) United States $0.411B 11.35
Geron (GERN) United States $0.411B 0.00
Amryt Pharma (AMYT) United Kingdom $0.406B 0.00
Orchard Therapeutics (ORTX) United Kingdom $0.394B 0.00
BeyondSpring (BYSI) United States $0.390B 0.00
SQZ Biotechnologies (SQZ) United States $0.389B 0.00
Selecta Biosciences (SELB) United States $0.380B 0.00
Gritstone Bio (GRTS) United States $0.379B 0.00
Athenex (ATNX) United States $0.372B 0.00
Starpharma Holdings (SPHRY) Australia $0.372B 0.00
XOMA (XOMA) United States $0.366B 171.10
CytomX Therapeutics (CTMX) United States $0.366B 0.00
BioDelivery Sciences (BDSI) United States $0.364B 14.76
Codiak BioSciences (CDAK) United States $0.362B 0.00
AquaBounty Technologies (AQB) United States $0.352B 0.00
INmune Bio (INMB) United States $0.350B 0.00
Neoleukin Therapeutics (NLTX) United States $0.346B 0.00
Athersys (ATHX) United States $0.342B 0.00
Theratechnologies (THTX) Canada $0.339B 0.00
Cel-Sci (CVM) United States $0.336B 0.00
UROGEN PHARMA (URGN) United States $0.334B 0.00
Cue Biopharma (CUE) United States $0.329B 0.00
Angion Biomedica (ANGN) United States $0.327B 0.00
Opthea (OPT) Australia $0.325B 0.00
WAVE Life Sciences (WVE) Singapore $0.325B 0.00
Puma Biotechnology (PBYI) United States $0.324B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.324B 0.00
Syros Pharmaceuticals (SYRS) United States $0.310B 0.00
Clearside Biomedical (CLSD) United States $0.309B 0.00
Fortress Biotech (FBIO) United States $0.307B 0.00
Talis Biomedical (TLIS) United States $0.300B 0.00
Adverum Biotechnologies (ADVM) United States $0.300B 0.00
IBio (IBIO) United States $0.294B 0.00
Cerecor (CERC) United States $0.277B 0.00
Fulcrum Therapeutics (FULC) United States $0.276B 0.00
Arbutus Biopharma (ABUS) United States $0.271B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.271B 0.00
Frequency Therapeutics (FREQ) United States $0.270B 0.00
Prima BioMed (IMMP) Australia $0.269B 0.00
Kaleido Biosciences (KLDO) $0.263B 0.00
Adicet Bio (ACET) United States $0.261B 0.00
Innate Pharma S.A (IPHA) France $0.261B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.259B 0.00
OVID THERAPEUTC (OVID) United States $0.259B 2.55
Trevena (TRVN) United States $0.257B 0.00
Cogent Biosciences (COGT) United States $0.256B 0.00
Chiasma (CHMA) United States $0.250B 0.00
Kamada (KMDA) Israel $0.247B 16.79
Kala Pharmaceuticals (KALA) United States $0.244B 0.00
CorMedix Inc (CRMD) United States $0.244B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.236B 0.00
OSMOTICA PHARM (OSMT) United States $0.224B 0.00
TELA Bio (TELA) United States $0.224B 0.00
Checkpoint Therapeutics (CKPT) United States $0.223B 0.00
Bellus Health (BLU) Canada $0.219B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.218B 0.00
ADMA Biologics Inc (ADMA) United States $0.203B 0.00
Cardiff Oncology (CRDF) United States $0.201B 0.00
HOOKIPA Pharma (HOOK) United States $0.198B 0.00
NextCure (NXTC) United States $0.198B 0.00
POXEL SA FRANCE (PXXLF) France $0.197B 0.00
Seelos Therapeutics (SEEL) United States $0.193B 0.00
Strongbridge Biopharma (SBBP) United States $0.184B 0.00
Aptinyx (APTX) United States $0.183B 0.00
Biofrontera AG (BFRA) Germany $0.183B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.181B 0.00
Beyond Air (XAIR) United States $0.180B 0.00
PHASEBIO PHARMA (PHAS) United States $0.175B 0.00
GENFIT S.A (GNFT) France $0.172B 0.00
Synlogic (SYBX) United States $0.171B 0.00
Nicox SA (NICXF) France $0.171B 0.00
VTv Therapeutics (VTVT) United States $0.168B 0.00
Applied Genetic Technologies (AGTC) United States $0.163B 0.00
VolitionRX (VNRX) United States $0.162B 0.00
Enzo Biochem (ENZ) United States $0.152B 44.86
ObsEva SA (OBSV) Switzerland $0.147B 0.00
Cyclerion Therapeutics (CYCN) United States $0.146B 0.00
Viridian Therapeutics (VRDN) United States $0.145B 0.00
Antibe Therapeutics (ATBPF) Canada $0.145B 0.00
X4 Pharmaceuticals (XFOR) United States $0.142B 0.00
Eton Pharmaceuticals (ETON) United States $0.139B 0.00
Catalyst Biosciences (CBIO) United States $0.138B 0.00
LogicBio Therapeutics (LOGC) United States $0.136B 0.00
Galena Biopharma (SLS) United States $0.136B 0.00
Erytech Pharma SA (ERYP) France $0.135B 0.00
ABVC BioPharma (ABVC) United States $0.133B 0.00
Liquidia Technologies (LQDA) United States $0.133B 0.00
Abeona Therapeutics (ABEO) United States $0.131B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.130B 0.00
Entera Bio (ENTX) Israel $0.130B 0.00
Orgenesis (ORGS) United States $0.130B 264.50
Purple Biotech (PPBT) Israel $0.128B 0.00
Exicure (XCUR) United States $0.126B 0.00
Voyager Therapeutics (VYGR) United States $0.125B 3.20
Eyenovia (EYEN) United States $0.123B 0.00
Palatin Technologies (PTN) United States $0.122B 0.00
F-star Therapeutics (FSTX) United Kingdom $0.121B 0.00
Novogen (KZIA) Australia $0.121B 0.00
Longeveron (LGVN) United States $0.118B 0.00
Vascular Biogenics (VBLT) Israel $0.116B 0.00
Cocrystal Pharma (COCP) United States $0.113B 0.00
Pluristem Therapeutics (PSTI) Israel $0.112B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.107B 0.00
Aytu BioPharma (AYTU) United States $0.106B 0.00
Liminal BioSciences (LMNL) Canada $0.103B 0.00
Armata Pharmaceuticals (ARMP) United States $0.100B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.099B 0.00
Dyadic (DYAI) United States $0.099B 0.00
Evofem Biosciences (EVFM) United States $0.095B 0.00
Celsion (CLSN) United States $0.095B 0.00
Aptevo Therapeutics (APVO) United States $0.092B 0.00
Yumanity Therapeutics (YMTX) United States $0.092B 0.00
Vyant Bio (VYNT) United States $0.092B 0.00
ARAVIVE, INC (ARAV) United States $0.091B 0.00
AEterna Zentaris (AEZS) United States $0.089B 0.00
Zosano Pharma (ZSAN) United States $0.085B 0.00
Leap Therapeutics (LPTX) United States $0.082B 0.00
AIkido Pharma (AIKI) United States $0.082B 0.00
Stealth BioTherapeutics (MITO) Cayman Islands $0.080B 0.00
Adocia (ADOCY) France $0.077B 0.00
Evogene (EVGN) Israel $0.077B 0.00
Protalix BioTherapeutics (PLX) Israel $0.076B 0.00
Cidara Therapeutics (CDTX) United States $0.075B 0.00
Cleveland BioLabs (CBLI) United States $0.073B 0.00
Emmaus Life Sciences (EMMA) United States $0.073B 0.00
DiaMedica Therapeutics (DMAC) United States $0.072B 0.00
ATyr Pharma (LIFE) United States $0.071B 0.00
Celyad SA (CYAD) Belgium $0.071B 0.00
Vaccinex (VCNX) United States $0.069B 0.00
Edesa Biotech (EDSA) Canada $0.069B 0.00
Lumos Pharma (LUMO) United States $0.066B 0.00
ARIDIS PHARMACT (ARDS) United States $0.066B 0.00
Advaxis (ADXS) United States $0.063B 0.00
Alimera Sciences (ALIM) United States $0.063B 0.00
Oncotelic Therapeutics (OTLC) United States $0.062B 0.00
BioCardia (BCDA) United States $0.061B 0.00
Cyclo Therapeutics (CYTH) United States $0.059B 0.00
TRACON Pharmaceuticals (TCON) United States $0.058B 0.00
Organovo Holdings (ONVO) United States $0.055B 0.00
Genetic Technologies (GENE) Australia $0.054B 0.00
Idera Pharmaceuticals (IDRA) United States $0.053B 0.00
Pulmatrix (PULM) United States $0.051B 0.00
AnPac Bio-Medical Science (ANPC) China $0.050B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.050B 0.00
Windtree Therapeutics (WINT) United States $0.049B 0.00
Happiness Biotech Group (HAPP) China $0.048B 0.00
Invo BioScience (INVO) United States $0.045B 0.00
Enveric Biosciences (ENVB) United States $0.043B 0.00
Soligenix (SNGX) United States $0.039B 0.00
Lexaria Bioscience (LEXX) Canada $0.038B 0.00
Timber Pharmaceuticals (TMBR) United States $0.037B 0.00
Acorda Therapeutics (ACOR) United States $0.036B 0.87
Vallon Pharmaceuticals (VLON) United States $0.033B 0.00
Prana Biotechnology (ATHE) Australia $0.031B 0.00
Benitec Biopharma (BNTC) United States $0.030B 0.00
GeoVax Labs (GOVX) United States $0.029B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.029B 0.00
ThermoGenesis Holdings (THMO) United States $0.029B 0.00
IMMURON (IMRN) Australia $0.028B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.024B 0.00
Titan Pharmaceuticals (TTNP) United States $0.023B 0.00
ZIVO Bioscience (ZIVO) United States $0.020B 0.00
Palisade Bio (PALI) United States $0.011B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.000B 0.00
ImmunityBio (IBRX) United States $0.000B 0.00
Immatics (IMTX) United States $0.000B 0.00
PDL BioPharma (PDLI) United States $0.000B 0.00